Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.)
Profile
Mailing Address: 2488 Dunwin Drive
Mississauga, Ontario
L5L 1J9
Head Office Address: 2488 Dunwin Drive
Mississauga, Ontario
L5L 1J9
Contact Name: James Parsons Principal Regulator: Ontario
Business e-mail address: james@trilliumtherapeutics.com Short Form Prospectus Issuer: Yes
Telephone Number: 416 595-0627 Reporting Jurisdictions: British Columbia, Alberta, Manitoba, Ontario, Nova Scotia
Fax Number: Stock Exchange: TSX, NASDAQ
Date of Formation: Mar 31 2004 Stock Symbol: TRIL
Jurisdiction Where Formed: Ontario Auditor: Ernst & Young LLP, Chartered Accountants
Industry Classification: consumer products - biotechnology/pharmaceuticals General Partner:
CUSIP Number: 89620X Transfer Agent: Computershare Investor Services Inc.
Financial Year-End: Dec 31 Size of Issuer (Assets): $25,000,001 to $100,000,000


View This Company's Documents